…ssment, wellness checks) in the short term, but it cannot substitute for in-person assessments and is unreliable in identifying patients who are progressing. As one person commented, “Virtual care is not the art of medicine.” That said, for some a hybrid approach may be preferable in the future to spare some patients, notably those living in remote regions, the inconvenience and cost of some in-person visits. The pandemic reinforced the view that…

…ned low (74.8/year). The most significant drops were seen for alemtuzumab (-64%), anti-CD20 agents (-49%), cladribine (-46%) and S1P receptor modulators (-38%). Prescriptions for natalizumab increased 24%, which likely reflected the need for a high-efficacy therapy with less of an impact on vaccine response. Results of a survey on DMT prescribing among Canadian neurologists during the pandemic will be posted in an upcoming article on NeuroSens. A…